跳至主要内容
临床试验/NCT06213090
NCT06213090招募中不适用

Patterns of Disease, Outcomes and Treatment Response in Children With Neurodevelopmental Disorders

Richard Frye1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2024年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000
试验地点
1
主要终点
Number of Patients with Specific Medical abnormalities

研究概览

简要总结

The purpose of this study is to systematically evaluate the results of medical investigations to identify symptom and biological patterns and common etiologies of neurodevelopmental disorders.

详细描述

Although neurodevelopmental disorders are very prevalent (for example Autism affects 1 out of every 36 children and dyslexia affects up to 15% of the population), the etiology of such disorders is not known. The purpose of this investigation is to identify common etiologies of neurodevelopmental disorders (i.e., speech delay, global developmental delay, autism) and determine if it is possible to find early indicators of the diagnosis and foster the potential for a better prognosis of these disorders. At this time the investigators examine patients with neurodevelopment disorders with various medical investigations, but the results of these investigations are not systematically evaluated. One of the goals of this research is to systematically examine this information in order to identify patterns of test abnormalities that have not been previously described. Another goal of this research is to identify the common etiologies typically identified by the medical evaluation, so we can further refine our approach. In addition, the investigators now have the ability to evaluate biological samples for biomarkers that have potential to be diagnostically useful.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Neurodevelopmental delays Clinical visit at an Rossignol Medical Center

排除标准

  • 未提供

研究组 & 干预措施

Cerebral Folate Deficiency

Children with Cerebral Folate Deficiency will be followed in regards to their clinical management.

PANS

Children with PANS will be followed in regards to their clinical management.

PANDAS

Children with PANDAS will be followed in regards to their clinical management.

Epilepsy

Children with Epilepsy will be followed in regards to their clinical management.

ADHD

Children with ADHD will be followed in regards to their clinical management.

Autism

Children with autism will be followed in regards to their clinical management.

Mitochondrial Encephalopathy

Children with Mitochondrial Encephalopathy will be followed in regards to their clinical management.

Down Syndrome

Children with Down Syndrome will be followed in regards to their clinical management.

Dyslexia and other learning disabilities

Children with Dyslexia and other learning disabilities will be followed in regards to their clinical management.

Other Neurodevelopmental Disorders

Children with Other Neurodevelopmental Disorders will be followed in regards to their clinical management.

结局指标

主要结局

Number of Patients with Specific Medical abnormalities

时间窗: up to 7 years

It is unknown if a specific set of biological abnormalities contribute to the formation of many types of neurodevelopmental disorders. The study is intended to identify the relationship between biological abnormalities and neurodevelopmental disorders. The chart will be reviewed for medical diagnoses other than the primary neurodevelopmental disorders.

次要结局

  • The number of children with abnormal clinical lab(up to 7 years)
  • The number of children who respond to specific treatments(up to 7 years)

研究者

发起方
Richard Frye
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Richard Frye

Principal Investigator

Rossignol Medical Center

研究点 (1)

Loading locations...

相似试验